LMR Partners’s AtriCure ATRC Stock Holding History

LMR Partners’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-16,313	Closed	-$499K	–	1371
2024 Q4	$499K	Buy	+16,313	New	+$525K	﹤0.01%	838
2014 Q2	–	Sell	-21,056	Closed	-$396K	–	465
2014 Q1	$396K	Buy	+21,056	New	+$431K	0.06%	156

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

LMR Partners's ATRC Position: Q1 2025 in Review

LMR Partners sold out of AtriCure (ATRC) in Q1 2025, closing a stake of 16,313 shares — an estimated $499K sold.

LMR Partners first reported a position in ATRC in Q1 2014 and held it in 2 quarters. The position peaked at $499K in Q4 2024. 221 funds tracked by Wall St. Rank hold ATRC as of Q1 2025.

LMR Partners reported no remaining AtriCure position as of Q1 2025 after selling out during the quarter.
LMR Partners sold 16,313 AtriCure shares in Q1 2025, an estimated $499K.
LMR Partners first reported a position in AtriCure in Q1 2014 and held it in 2 quarters.
LMR Partners's AtriCure position peaked at $499K in Q4 2024.
221 funds tracked by Wall St. Rank held AtriCure as of Q1 2025.

Based on LMR Partners's 13F filing for Q1 2025, filed 15 May 2025.